Status:
COMPLETED
Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Correlation between MRS and Tumor Response Therapy in Breast Cancer.
Detailed Description
Correlation between MRS (Magnetic Resonance Spectroscopy and Tumor Response to Radiation in Breast Cancer
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically confirmed diagnosed Breast cancer
- Patient is 18 years or older
- Karnofsky performance score \> 70
- No previously irradiated or recurrent breast cancer
- No contraindication to MRS/MRI
- Signed informed consent.
Exclusion
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01428739
Start Date
December 1 2007
End Date
September 1 2014
Last Update
January 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2